Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2017 17:00 ET | Source: Osiris Therapeutics, Inc.

Osiris Therapeutics Announces Scientific Manuscript Reporting Antimicrobial Properties of Cryopreserved Viable Amnion is Available Electronically in Peer-Reviewed Journal

COLUMBIA, Md., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), announced today that a new peer-reviewed manuscript “Human cryopreserved viable amniotic membrane...
December 02, 2016 17:00 ET | Source: Osiris Therapeutics, Inc.

Osiris Provides Update Regarding NASDAQ Listing Matters

COLUMBIA, Md., Dec. 02, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the “Company”) today provided an update regarding the status of its compliance with the Listing Rules of...
November 22, 2016 17:00 ET | Source: Osiris Therapeutics, Inc.

Peer-reviewed Publication on the use of Grafix® in High-Risk Peripheral Arterial Disease Patients with Treatment Refractory Ulcerations Demonstrating Durable Wound Closure

COLUMBIA, Md., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced today that a new peer-reviewed manuscript by physician and surgeon Jonathan Smedley, DPM, FACFAS,...
November 21, 2016 17:00 ET | Source: Osiris Therapeutics, Inc.

Osiris Provides Update Regarding NASDAQ Listing Matters

COLUMBIA, Md., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the “Company”) today provided an update regarding the status of its compliance with the Listing Rules of...
November 07, 2016 17:00 ET | Source: Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc. Reports Preliminary 2014 and 2015 Revenue and Anticipated 2016 Revenue

COLUMBIA, Md., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...
October 31, 2016 16:30 ET | Source: Osiris Therapeutics, Inc.

Peer-reviewed Publication on the use of Grafix® Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware

COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...
October 26, 2016 16:30 ET | Source: Osiris Therapeutics, Inc.

Grafix® Cost Comparative Manuscript Reporting Wound Care Cost Reduction is Available Electronically in a Peer-Reviewed Journal

COLUMBIA, Md., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...
October 18, 2016 16:30 ET | Source: Osiris Therapeutics, Inc.

Osiris to Present Clinical and Scientific Studies at Desert Foot 2016

COLUMBIA, Md., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing and marketing products to treat conditions...
October 11, 2016 16:30 ET | Source: Osiris Therapeutics, Inc.

Net Health and Osiris Therapeutics Announce the Broad Availability of Grafix® to Wound Care Patients Due to WoundExpert® EMR Integration

PITTSBURGH, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Net Health, the leading provider of software solutions for specialized outpatient care, announced today that their partnership with Osiris...
October 06, 2016 17:00 ET | Source: Osiris Therapeutics, Inc.

Osiris to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care (SAWC)

COLUMBIA, Md., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading regenerative medicine company focused on developing and marketing products to treat conditions...